Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $14.6M | -- | -- | -$0.80 | -- |
| 11/04/2025 | Q3 | $23.6M | $2.8M | -$0.94 | -$0.78 | -$0.16 |
| 08/11/2025 | Q2 | $24.2M | $11.5M | -$0.95 | -$0.80 | -$0.15 |
| 05/08/2025 | Q1 | $10.7M | $22.1M | -$0.82 | -$0.91 | $0.09 |
| 02/27/2025 | Q4 | $14.8M | $7.4M | -$0.88 | -$0.79 | -$0.10 |
| 10/31/2024 | Q3 | $10.3M | $3.7M | -$0.82 | -$0.84 | $0.02 |
| 08/07/2024 | Q2 | $12.6M | $25.7M | -$0.58 | -$0.66 | $0.08 |
| 05/02/2024 | Q1 | $13.1M | $10.3M | -$0.69 | -$0.72 | $0.03 |
| 02/22/2024 | Q4 | $42M | $47.9M | -$0.25 | -$0.38 | $0.13 |
| 11/02/2023 | Q3 | -- | $4.7M | -$0.90 | -- | -- |
| 08/03/2023 | Q2 | -- | $16.5M | -$0.67 | -- | -- |
| 05/04/2023 | Q1 | -- | $9.5M | -$0.70 | -- | -- |
| 02/23/2023 | Q4 | -- | $16.1M | -$0.60 | -- | -- |
| 11/03/2022 | Q3 | -- | $9.6M | -$0.79 | -- | -- |
| 08/09/2022 | Q2 | -- | $11.5M | -$0.78 | -- | -- |
| 05/03/2022 | Q1 | -- | $9.6M | -$0.71 | -- | -- |
| 02/24/2022 | Q4 | -- | $15.3M | -$0.66 | -- | -- |
| 11/10/2021 | Q3 | -- | $20.3M | -$0.56 | -- | -- |
| 08/06/2021 | Q2 | -- | $18.5M | -$0.55 | -- | -- |
| 05/06/2021 | Q1 | -- | $18.7M | -$0.29 | -- | -- |
| 03/11/2021 | Q4 | -- | $12.8M | -$0.29 | -- | -- |
| 11/05/2020 | Q3 | -- | $14.5M | -$0.39 | -- | -- |
| 06/30/2020 | Q2 | -- | $3.3M | -$0.32 | -- | -- |
| 03/31/2020 | Q1 | -- | $3.4M | -$0.45 | -- | -- |
| 12/31/2019 | Q4 | -- | $1.8M | -$0.26 | -- | -- |
| 09/30/2019 | Q3 | -- | $950K | -$0.26 | -- | -- |
Kymera Therapeutics, Inc. reported $2.8M worth of top line sales in its most recent quarter.
Kymera Therapeutics, Inc. announced earnings per share of -$0.94 which represents a miss of analyst forecast a -$0.78 per share.
Kymera Therapeutics, Inc. reported $615K that represents $0.01 per share over the last quarter.
Kymera Therapeutics, Inc.'s earnings are forecast to decrease from -$2.98 per share to -$2.84 per share next year representing a decrease of -16.55%.
Kymera Therapeutics, Inc.'s next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
With the market starting to look skittish on pure-play AI…
Market Cap: $4.4T
P/E Ratio: 62x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.9T
P/E Ratio: 40x
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.